Dynamic changes of tissue factor pathway inhibitor type 2 associated with IL-1β and TNF-α in the development of murine acute lung injury

Zhengwu Li,Zuohua Mao,Yifeng Lin,Wang Liang,Fanglin Jiang,Jin Liu,Qiqun Tang,Duan Ma

DOI: https://doi.org/10.1016/j.thromres.2008.03.019

IF: 10.407

2008-01-01

Thrombosis Research

Abstract:Acute lung injury (ALI) and its severe form, acute respiratory distress syndrome (ARDS), are frequent in critically ill patients with widespread lung inflammation, and are responsible for significant morbidity and mortality [ 1 Ware L.B. Matthay M.A. The Acute Respiratory Distress Syndrome. N Engl J Med. 2000; 342: 1334-1349 Crossref PubMed Scopus (4436) Google Scholar , 2 Bernard G.R. Acute Respiratory Distress Syndrome: A Historical Perspective. Am J Respir Crit Care Med. 2005; 172: 798-806 Crossref PubMed Scopus (152) Google Scholar ]. It is known that the inflammatory cascade plays an important role and interleukin-Iβ (IL-1β) and tumor necrosis factor-α (TNF-α) have been considered as the pivotal mediators in the development of ALI [ [3] Yeh C.C. Kao S.J. Lin C.C. Wang S.D. Liu C.J. Kao S.T. The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sci. 2007; 80: 1821-1831 Crossref PubMed Scopus (120) Google Scholar ]. Although significant advances have made in the past few decades, the mortality associated with ALI remains unchanged.